News | RIVM

More than two million invitations to get vaccinated against HPV in 2023

In early 2023, 1.3 million young adults will receive an invitation to get vaccinated against the human papillomavirus (HPV). This group comprises around 900,000 men and 400,000 women between the ages of 19 and 27.

Nationwide study into chlamydia and gonorrhoea

Today, the National Institute for Public Health and the Environment (RIVM) launches a nationwide study into chlamydia and gonorrhoea.

Almost half of 9 and 10-year-olds get HPV vaccination at first opportunity

This spring, more than 800,000 young people received an invitation to be vaccinated against HPV, the human papillomavirus.

Number of STI tests at sexual health centres are rising again

In 2021, more than 138,000 people were tested for sexually transmitted infections (STIs) at a centre for sexual health.

More STI tests conducted by Sexual Health Centres

In 2021, more people visited a Sexual Health Centre (SHC) to get tested for sexually transmitted infections (STIs) than in 2020. This figure is still lower than in 2019, the year before the coronavirus outbreak.

RIVM expands HPV vaccination programme: girls and boys protected from six types of cancer with one vaccine

Now not only girls, but also boys will have the opportunity to protect themselves from cancer caused by HPV.

Jongen en meisjes poseren op een kruk voor campagneposter HPV vaccin

Menthol facilitates inhalation of tobacco smoke, even when you cannot taste it

Even when menthol cannot be tasted, the substance makes it easier to inhale tobacco smoke. This way, menthol makes smoking more attractive for young and novice smokers who are not yet used to inhaling sharp, pungent tobacco smoke.

Increase in gonorrhoea and syphilis diagnoses

The number of people who got themselves tested for a sexually transmitted infection (STI) at a Sexual Health Centre (SHC) in 2019 has remained almost the same as in 2018.

State Secretary Blokhuis: boys will also be vaccinated against HPV virus

The vaccine against the HPV human papillomavirus virus will also become available for boys.

Research: HPV vaccine is safe

RIVM research shows no causal link between the vaccine against cervical cancer (HPV) and long-term fatigue symptoms in girls.